Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AMGN | VRTX | REGN | GSK |
| Company | Orphazyme A/S ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9060 | 306.79 | 455.00 | 980.16 | 41.22 |
| High | 0.9571 | 311.48 | 471.39 | 1,001.04 | 41.72 |
| Low | 0.8457 | 303.85 | 453.73 | 979.26 | 40.51 |
| Last | 0.8700 | 307.42 | 470.18 | 989.48 | 40.88 |
| Change | -0.0200 | +1.57 | +14.84 | +9.32 | -3.89 |
| % Change | -2.25% | +0.51% | +3.26% | +0.95% | -8.69% |
| Volume | 941,400 | 2,447,400 | 1,971,100 | 532,900 | 13,483,801 |
| 20-Day Average Volume | 1,980,090 | 2,592,560 | 1,259,920 | 388,930 | 3,955,380 |
| Previous Close | 0.8900 | 305.85 | 455.34 | 980.16 | 44.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 307.91 | 437.75 | 976.30 | 44.56 |
| 20-Day Raw Stochastic | 41.76% | 45.97% | 98.44% | 77.23% | 6.83% |
| 20-Day Relative Strength | 36.52% | 57.51% | 71.85% | 59.71% | 38.64% |
| Weighted Alpha | -87.89 | +36.15 | +44.02 | +32.24 | +15.58 |
| Today's Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +0.52% since 05/24/24 | +2.90% since 05/24/24 | +0.45% since 05/24/24 | -9.40% since 05/24/24 |
| Low | 0.8275 on 03/29/22 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 0.9600 on 03/29/22 | 311.48 on 06/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -1.24% since 05/03/24 | +17.23% since 05/03/24 | +3.39% since 05/03/24 | -6.02% since 05/03/24 |
| Low | 0.5101 on 03/14/22 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 40.51 on 06/03/24 |
| High | 1.3720 on 03/10/22 | 321.44 on 05/15/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | +9.66% since 03/01/24 | +8.65% since 03/01/24 | +0.68% since 03/01/24 | -2.74% since 03/01/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 2.7500 on 01/03/22 | 322.60 on 05/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +12.84% since 12/01/23 | +33.89% since 12/01/23 | +21.43% since 12/01/23 | +11.79% since 12/01/23 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 347.51 on 12/04/23 | 802.55 on 12/04/23 | 35.81 on 12/07/23 |
| High | 5.4900 on 10/13/21 | 329.72 on 02/05/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 164,068,656 | 117,501,856 | 107,999,904 | 92,783,136 |
| Shares Outstanding, K | 35,312 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -97,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.68 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 04/05/22 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.16 | 29.42 | 26.14 | 10.90 |